CD274 and neoplasm: The discontinuation of PD-1/PD-L1 blockade in the context of OPD could lead to the subsequent progression of currently non-progressive lesions in the absence of an autonomous efficient anti-tumor immune response, especially in patients who presented with multiple other disease sites before immunotherapy treatment.